¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"solubility limit"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • solubility limit
    ¿ëÇØÇѵµ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • bile solubility test
    ¾µ°³Áó¿ëÇØµµ°Ë»ç, ´ãÁó¿ëÇØµµ°Ë»ç
  • blood gas solubility coefficient
    Ç÷¾×°¡½º¿ëÇØ°è¼ö
  • gas solubility coefficient
    °¡½º¿ëÇØ°è¼ö
  • lipid solubility
    ÁöÁú¿ëÇØµµ
  • mutual solubility
    »óÈ£¿ëÇØµµ
  • solubility
    ¿ëÇØµµ
  • solubility coefficient
    ¿ëÇØ°è¼ö
  • solubility curve
    ¿ëÇØµµ°î¼±
  • solubility test
    ¿ëÇØµµ°Ë»ç
  • audibility limit
    °¡Ã»ÇѰè
  • age limit
    Á¤³â
  • limit
    ÇѰè
  • limit dextrin
    ÇѰ赦½ºÆ®¸°
  • maximum allowable limit
    ÃÖ´ëÇã¿ëÇѰè
  • maximum permissible limit
    ÃÖ´ëÇã¿ëÇѰè
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • limit
    ÇѰè
  • solubility
    ¿ëÇØµµ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • solubility limit
    ¿ëÇØÇѵµ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • bile solubility test
    ´ãÁó¿ëÇØµµ°Ë»ç
  • blood gas solubility coefficient
    Ç÷¾×°¡½º¿ëÇØ°è¼ö
  • gas solubility coefficient
    °¡½º¿ëÇØ°è¼ö
  • solubility coefficient
    ¿ëÇØ°è¼ö
  • solubility curve
    ¿ëÇØµµ°î¼±
  • lipid solubility
    ÁöÁú¿ëÇØµµ
  • mutual solubility
    »óÈ£¿ëÇØµµ
  • solubility
    ¿ëÇØµµ
  • solubility test
    ¿ëÇØµµ½ÃÇè
  • age limit
    Á¤³â
  • audible limit
    °¡Ã»ÇѰè
  • limit dextrin
    ÇѰ赦½ºÆ®¸°
  • limit
    ÇѰè
  • maximum allowable limit
    ÃÖ´ëÇã¿ëÇѰè
  • maximum permissible limit
    ÃÖ´ëÇã¿ëÇѰè
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • gas solubility coefficient
    °¡½º¿ëÇØµµ°è¼ö.
  • Nyquist limit
    ³ªÀÌÄû½ºÆ® ÇѰè
  • age limit
    Á¤³â(ËøËç).
  • annual limit on intake (ALI)
    ¿¬°£Èí¼öÁ¦ÇÑ, ¿¬°£Èí¼öÇѵµ
  • practical residue limit =PRL
    ½ÇÁ¦ÀÜ·ùÇѰè.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • solubility limit
    ¿ëÇØÇѵµ(éÁú°ùÚöô).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • bile solubility test
    ´ãÁó¿ëÇØµµ½ÃÇè(¡­éÁú°öôãËúÐ).
  • bile solubility test
    ´ãÁó¿ëÇØµµ°Ë»ç
  • bile solubility test
    ´ãÁó¿ëÇØµµ½ÃÇè
  • dithionite solubility test
    µðƼ¿À´ÏÆ®¿ëÇØµµ½ÃÇè
  • enamel solubility
    ¹ý³¶Áú¿ëÇØµµ.
  • gas solubility coefficient
    °¡½º¿ëÇØµµ°è¼ö.
  • lipid solubility
    ÁöÁú¿ëÇØµµ, Áö¿ë¼º.
  • mutual solubility
    »óÈ£¿ëÇØµµ(¡­éÁú°öô).
  • solubility
    ¿ëÇØµµ(éÁú°Óø)
  • solubility
    ¿ëÇØµµ(éÁú°öô).
  • solubility coefficient
    ¿ëÇØ(µµ)°è¼ö(éÁú°öô Ìõâ¦).
  • solubility curve
    ¿ëÇØµµ°î¼±(¡­ÍØàÊ).
  • solubility test
    ¿ëÇØµµ½ÃÇè(¡­ãËúÐ).
  • age limit
    Á¤³â(ËøËç).
  • annual limit on intake (ALI)
    ¿¬°£Èí¼öÁ¦ÇÑ, ¿¬°£Èí¼öÇѵµ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Bunsen solubility coefficient
    ºÐÁ¨ ¿ëÇØµµ°è¼ö(éÁú°ÓøÌõâ¦)
  • solubility
    ¿ëÇØµµ(éÁú°Óø)
  • solubility curve
    ¿ëÇØµµ °î¼±(éÁú°ÓøÍØàÊ)
  • solubility product
    ¿ëÇØµµ(éÁú°Óø) °ö
  • exclusion limit
    ¹èÁ¦ÇѰè (ÛÉð¶ùÚÍ£)
  • exclusion limit chromatography
    ¹èÁ¦ÇѰè (ÛÉð¶ùÚÍ£) Å©·Î¸¶Åä±×·¡ÇÇ
  • limit dextrin
    ÇѰè(ùÚÍ£)µ¦½ºÆ®¸°
  • limit dextrinosis
    ÇѰè(ùÚÍ£)ÅØ½ºÆ®¸°Áõ(ñø)
  • threshold limit value
    ¹®ÅÎ ÇѰè(ùÚÍ£)°ª
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Nyquist limit
    ³ªÀÌÄû½ºÆ®ÇѰè
  • solubility
    ¿ëÇØµµ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
LCL Levinthal-Coles-Lillie [body]; lower confidence limit; lower control limit; lymphoblastoid cell line...
UCL ulnar collateral ligament; upper collateral ligament; upper confidence limit; upper control limit; u...
'Greek letter alpha' angular acceleration; first [carbon atom next to the carbon atom bearing the active group in organic...
CMS children's medical services; Christian Medical Society; chronic myelodysplastic syndrome; chromosome...
Ksp solubility product
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
95% CL 95% confidence limit
DL Detection limit
LOD Limit of detection
LOQ Limit of quantitation
MRL Maximum Residue Limit
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • bile solubility test
    ´ãÁó ¿ëÇØ ½ÃÇè
  • solubility
    ¿ëÇØµµ
    Æ÷È­ ¿ë¾× ¼Ó¿¡ µé¾î ÀÖ´Â ¿ëÁúÀÇ ³óµµ.
  • solubility test
    ¿ëÇØµµ ½ÃÇè, ¿ëÇØ¼º ½ÃÇè
  • check limit
    °¨»ç ÇѰè
  • confidence limit
    ½Å·Ú ÇѰè
  • dose limit
    ¼±·® Çѵµ, ¼±·® Á¦ÇÑ
  • dose-equivalent limit
    ¼±·® ´ç·® Çѵµ
  • elastic limit
    ź¼º ÇѰè, ź¼º Çѵµ
    1. ¿Ü·ÂÀÇ ÀÛ¿ë½Ã Àç·á°¡ ¿µ±¸ º¯ÇüÀ» ³²±âÁö ¾Ê´Â ÃÖ´ë ÀÀ·Â. 2. ÇÏÁßÀ» Á¦°ÅÇÒ ¶§¿¡º¯ÇüÀÌ 0ÀÌ µÇ¾î, Àç·á°¡ ¿ø·¡ÀÇ »óÅ·ΠµÇµ¹¾Æ ¿Ã ¼ö ÀÖ´Â ÃÖ´ë ÀÀ·Â.
  • limit
    ÇѰè
  • limit of dullness
    ŹÀ½ °æ°è
  • lower limit
    ÇÏÇÑ
  • maximum allowable limit
    ÃÖ´ë Çã¿ë ÇѰè
  • maximum permissible limit
    ÃÖ´ë Çã¿ë ÇѰè
  • median tolerance limit
    ¹Ý¼ö »ýÁ¸ ÇÑ°è ³óµµ
  • proportional limit
    ºñ·Ê ÇѰè
    1. º¯Çü¿¡ ºñ·ÊÇÏ¿© Áõ°¡ÇÏ´Â ÃÖ´ë ÀÀ·Â. 2. ÀÀ·Â°ú º¯Çü·ü »çÀÌ¿¡ Á¤ºñ·Ê °ü°è°¡ ¼º¸³ÇÏ´Â ¿µ¿ªÀÇ ÃÖ´ë ÀÀ·Â. 3. °¡ÇØÁø ¿Ü·Â¿¡ ºñ·ÊÇØ º¯ÇüÀÌ ÀϾ´Â ÇѰè ÀÀ·Â ÀÌ»óÀÇ ÀÀ·Â.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
bile solubility test A procedure that differentiates Streptococcus pneumoniae from other alpha-haemolytic streptococci by demonstrating its susceptibility to lysis in the presence of bile.
(05 Mar 2000)
Bunsen's solubility coefficient The milliliters of gas STPD dissolved per milliliter of liquid and per atmosphere (760 mm Hg) partial pressure of the gas at any given temperature.
(05 Mar 2000)
solubility 1. The quality, condition, or degree of being soluble or solvable; as, the solubility of a salt; the solubility of a problem or intricate difficulty.
2. <botany> The tendency to separate readily into parts by spurious articulations, as the pods of tick trefoil.
Origin: Cf. F. Solubilite.
Source: Websters Dictionary
(01 Mar 1998)
solubility test A screening test for sickle cell haemoglobin (Hb S), which is reduced by dithionite and is insoluble in concentrated inorganic buffer; addition of blood showing Hb S to buffer and dithionite causes opacity of the solution.
(05 Mar 2000)
Ostwald's solubility coefficient The milliliters of gas dissolved per milliliter of liquid and per atmosphere (760 mm of Hg) partial pressure of the gas at any given temperature. This differs from Bunsen's solubility coefficient (a) in that the amount of dissolved gas is expressed in terms of its volume at the temperature of the experiment, instead of STPD. Thus, lambda = a (1 + 0.00367t), where t = temperature in degrees Celsius.
(05 Mar 2000)
Abbe limit <physics> Ernst Abbe's specification for the limit of resolution of a diffraction-limited micro-scope. According to Abbe, a detail with a particular spacing in the specimen is resolved when the numerical aperture of the objective lens is large enough to capture the first-order diffraction pattern produced by the detail at the wavelength employed.
See: Rayleigh criterion, Sparrow limit.
(05 Aug 1998)
beta limit <radiobiology> if the plasma pressure in a tokamak becomes too high, the so-called ballooning modes become unstable and lead to a loss of confinement (sometimes catastrophic, sometimes not). The exact value at which this occurs depends strongly on the magnetic field B, the plasma minor radius a, and the toroidal plasma current I, such that maximum value of the normalised beta, beta_N=betaBa/I, is around 4% (with B in Teslas, a in metres, and I in Mega-amperes). The exact value depends on details of the plasma shape, the plasma profiles, and the safety factor.
Synonym: troyon limit.
(09 Oct 1997)
visibility, limit of <microscopy> For the normal eye, the limit of visibility is considerably below the limits of resolution. It depends largely on contrast and intensity of illumination.
(05 Aug 1998)
central limit theorem The sum (or average) of n realizations of the same process, provided only that it has a finite variance, will approach the gaussian distribution as n becomes indefinitely large. This theory provides a broad warrant for the use of normal theory even for nongaussian data. In the form stated here, it constitutes the classical version; more general versions allow serious relaxation of the usual assumptions.
(05 Mar 2000)
permissible exposure limit An occupational health standard to safeguard workers against dangerous contaminants in the workplace.
(05 Mar 2000)
control limit A regulatory value applied to the airborne concentration in the workplace of a potentially poisonous substance which is judged to be reasonably practicable for the whole spectrum of work activities and which must not normally be exceeded.
(09 Oct 1997)
Hayflick's limit <cell culture> The limit of human cell division in subcultures; such cells will divide only about 50 times before dying out.
(05 Mar 2000)
proportional limit The greatest stress that a material is capable of sustaining without any deviation from proportionality of stress to strain (Hooke's law).
(05 Mar 2000)
short-term exposure limit The maximum concentration of a chemical to which workers may be exposed continuously for up to 15 minutes without danger to health or work efficiency and safety.
(05 Mar 2000)
sparrow limit <microscopy> The spatial frequency at which the modulation transfer function just becomes 0.
See: Abbe limit, Rayleigh criterion.
(05 Aug 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • solubility
    ¿ëÇØ¼º
  • solubility
    ³ìÀ½;¿ëÇØ¼º;°¡¿ë¼º;¿ëÇØµµ;(¹®Á¦,Àǹ® µîÀÇ)ÇØ¼®(ÇØ°á)°¡´É¼º
  • limit
    Á¦ÇÑ,ÇÑÁ¤ÇÏ´Ù
  • Eddington('s) limit
    (õ)¿¡µùÅÏ ÇÑ°è ±¤µµ(ÀÏÁ¤ Áú·®ÀÇ ÃµÃ¼°¡ ³¾ ¼ö ÀÖ´Â ºûÀÇ ÃÖ´ëÇÑÀÇ ¹à±â)
  • Hayfield limit
    ÇìÀÌÇø¯ ÇѰè(¹è¾ç±â ¼Ó¿¡¼­ ¼¼Æ÷°¡ »ýÁ¸ÇÏ´Â ÇѰè)
  • debt limit
    乫 Çѵµ¾×;äºÎ ÇѰè
  • elastic limit
    (¹°)ź¼º ÇѰè
  • frozen limit
    (°ßµô¼ö ÀÖ´Â) ±ØÇÑ
  • limit
    ÇѰè;Çѵµ;Á¦ÇÑ;°æ°è;to the ~ ±Ø´ÜÀûÀ¸·Î;within the ~s of ...ÀÇ ¹üÀ§³»¿¡
  • limit
    ÇÑÁ¤(Á¦ÇÑ)ÇÏ´Ù
  • speed limit
    Á¦ÇѼӵµ
  • threemile limit
    ÇØ¾È¿¡¼­ 3¸¶ÀÏ À̳»ÀÇ ÇѰè(¿µÇØ)
  • time limit
    ½ÃÇÑ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á